NCT00888355View on ClinicalTrials.gov

MK0954 Versus Placebo for Treatment of Mild to Moderate Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

428

Participants

Timeline

Start Date

May 31, 1992

Primary Completion Date

January 31, 1993

Study Completion Date

February 28, 1993

Conditions
Hypertension
Interventions
DRUG

losartan potassium

losartan tablet (MK0954) 25 or 50 mg q.a.m. or 25 mg b.i.d., for 12 weeks

DRUG

Comparator: placebo

placebo to losartan tablet q.a.m. , for 12 weeks

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00888355 - MK0954 Versus Placebo for Treatment of Mild to Moderate Hypertension | Biotech Hunter | Biotech Hunter